Smoking, alcohol consumption may lead to prolonged feeding tube use in head and neck cancer
the ONA take:
A recent study found that current smoking and heavy alcohol consumption appear to be risk factors for prolonged use of a gastrostomy tube (GT) in patients with head and neck squamous cell carcinoma (SCC) undergoing radiotherapy or chemoradiotherapy.
This study included patients with head and neck SCC undergoing treatment at a teaching hospital in Ireland; 84 patients were undergoing chemoradiation and 20 patients, radiotherapy alone.
The median duration of GT use was 9 months, and GT use at 12 months was 35%. Risk factors for prolonged GT use was current heavy alcohol consumption and current smoking; however, multivariate analyses showed only current smoking to be an independent risk factor.
The researchers hypothesize that several reasons may explain why smoking and drinking might have an effect. Nicotine may suppress appetite and heavy alcohol consumption may lead to poor motivation to resume eating after treatment.
Further studies would be needed to determine if stopping smoking and drinking can shorten duration of GT use.
Smoking and alcohol consumption are risk factors for use of a gastrostomy tube in head and neck squamous cell carcinoma (SCC).
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|